Celltrion Pharm

068760.KQ

33.08 USD

-0.22

-0.66%

Overview

Last close

33.08 usd

Market cap

1.44B usd

52 week high

93.83 usd

52 week low

30.18 usd

Target price

95.51 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

7.5062

Price/Book Value

5.1681

Enterprise Value

1.51B usd

EV/Revenue

4.5076

EV/EBITDA

37.5519

Key financials

Revenue TTM

192.94M usd

Gross Profit TTM

56.77M usd

EBITDA TTM

30.05M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

454.19M usd

Net debt

74.22M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.